Kingworld Medicines Group Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
82.00
94.00
69.00
72.00
65.00
69.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
55.00
-34.00
108.00
-18.00
17.00
53.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
142.00
75.00
217.00
97.00
141.00
148.00
Cash Flow from Investing Activities
-37.00
-173.00
-111.00
-71.00
-19.00
-22.00
Cash Flow from Financing Activities
-39.00
16.00
-46.00
-94.00
41.00
-182.00
Net Cash Inflow / Outflow
66.00
-75.00
63.00
-75.00
154.00
-53.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
6.00
3.00
-7.00
-9.00
2.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Kingworld Medicines Group Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
82.858554492206
-42.294
124.00
295.91%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
55.7616322202266
20.656
35.00
169.95%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
142.618804243605
-6.626
148.00
2252.41%
Cash Flow from Investing Activities
-37.8253171936038
-0.307
-37.00
-12220.95%
Cash Flow from Financing Activities
-39.1198804615593
-1.01
-38.00
-3773.26%
Net Cash Inflow / Outflow
66.8109573992336
-7.467
73.00
994.75%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.13735081079171
0.476
1.00
138.94%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 89.67% vs -65.39% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
142.62
75.19
89.67%






